Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behrouz Mansouri Taleghani

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Cancers|February 25, 2022
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AMLEkaterina Gurevich, Michael Hayoz, Yolanda Aebi, et al.
Leukemia Research|June 26, 2012
The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potentialIsabelle von Grünigen, Joëlle Raschle, Ilka Rüsges-Wolter, et al.
Hematological Oncology|August 16, 2018
Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patientsSarah Farag, Barbara Jeker, Ulrike Bacher, et al.
Hematological Oncology|August 3, 2022
Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patientsMelanie Maechler, Ulrike Bacher, Michael Daskalakis, et al.
British Journal of Haematology|September 13, 2014
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemiaDana Wetzel, Beatrice U Mueller, Behrouz Mansouri Taleghani, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 24, 2014
A Simple Guideline Reduces the Need for Red Blood Cell Transfusions in Swiss Hospitals: A Prospective, Multicentre, Before-and-After Study in Elective Hip and Knee ReplacementStefano Fontana, Cristina de la Cuadra, Urs Müller, et al.
Transfusion|September 12, 2018
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemiaLaura C Alva, Ulrike Bacher, Katja Seipel, et al.
Transfusion Medicine Reviews|February 1, 2021
Immunoadsorption for the Treatment of Acquired Hemophilia: New Observational Data, Systematic Review, and Meta-AnalysisMichael Esteves Pereira, Christoph Bocksrucker, Johanna Anna Kremer Hovinga, et al.
Leukemia & Lymphoma|August 22, 2015
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicityBeatrice U Mueller, Sandra Keller, Katja Seipel, et al.
Hematological Oncology|January 25, 2018
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograftUrsina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Cancers|February 25, 2022
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AMLEkaterina Gurevich, Michael Hayoz, Yolanda Aebi, et al.
Leukemia Research|June 26, 2012
The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potentialIsabelle von Grünigen, Joëlle Raschle, Ilka Rüsges-Wolter, et al.
Hematological Oncology|August 16, 2018
Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patientsSarah Farag, Barbara Jeker, Ulrike Bacher, et al.
Hematological Oncology|August 3, 2022
Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patientsMelanie Maechler, Ulrike Bacher, Michael Daskalakis, et al.
British Journal of Haematology|September 13, 2014
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemiaDana Wetzel, Beatrice U Mueller, Behrouz Mansouri Taleghani, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 24, 2014
A Simple Guideline Reduces the Need for Red Blood Cell Transfusions in Swiss Hospitals: A Prospective, Multicentre, Before-and-After Study in Elective Hip and Knee ReplacementStefano Fontana, Cristina de la Cuadra, Urs Müller, et al.
Transfusion|September 12, 2018
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemiaLaura C Alva, Ulrike Bacher, Katja Seipel, et al.
Transfusion Medicine Reviews|February 1, 2021
Immunoadsorption for the Treatment of Acquired Hemophilia: New Observational Data, Systematic Review, and Meta-AnalysisMichael Esteves Pereira, Christoph Bocksrucker, Johanna Anna Kremer Hovinga, et al.
Leukemia & Lymphoma|August 22, 2015
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicityBeatrice U Mueller, Sandra Keller, Katja Seipel, et al.
Hematological Oncology|January 25, 2018
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograftUrsina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, et al.
Pageof 8